QAI: Powered Microneedle Device

Product code QAI, “Powered Microneedle Device” in FDA's classification database, is a Class II device type under 21 CFR 878.4430 (microneedling device for aesthetic use), reviewed by FDA's General, Plastic Surgery panel. FDA's 510(k) database lists 26 clearances under QAI, 26 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
QAI
Regulation
21 CFR 878.4430
Class
II
Panel
General, Plastic Surgery
Clearances
26
Most recent
May 13, 2026
Median review, last 2 years
171 days
Third-party review
Not eligible
Implant
No

What it covers

A powered microneedle device is a device using one or more needles to mechanically puncture and injure skin tissue for aesthetic use.

FDA’s definition of product code QAI, from the Product Classification database.

Recent clearances

510(k)DeviceApplicantDecisionType
K252591Automatic Micro Needle System (CODE-X)Woorhi Mechatronics Co., Ltd.May 13, 2026Traditional
K253002SkinStylus SteriLock MicroSystem (MP1209SL)Esthetic Medical, Inc.Feb 19, 2026Traditional
K252752ellacor System with Micro-Coring TechnologyCytrellis Biosystems, Inc.Oct 30, 2025Traditional
K253153SER Pen Carain MicroSystem (MP1209SP)Su-Ko Technologies, LLCOct 29, 2025Special
K243800PRO Pen Microneedling System (6883)Dermalogica, LLCAug 25, 2025Traditional
K243143E-PEN (E-PEN)Bomtech Electronics Co., Ltd.Apr 7, 2025Traditional
K2434721NEED ProCampomats S.R.L.Mar 19, 2025Traditional
K241790XCELLARISPRO TWIST microneedling deviceDermaroller GmbHMar 6, 2025Traditional
K241355SER Pen Carain MicroSystem (MP1209SP)Su-Ko Technologies, LLCOct 9, 2024Traditional
K241400SkinPen Precision Elite SystemCrown AestheticsAug 29, 2024Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 26 with a free account)

Clearances by year

26 QAI 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)2212
20256160
20243104
20232141
20224172
20214226
20202169
20191318
20182385

Who submits

18 applicants cleared a QAI device since 2011. 69% of the clearances went to applicants in United States, then Germany (15%), South Korea (8%) and China (4%). By type: Traditional 88%, Special 8% and Direct 4%.

ApplicantClearances since 2011
Crown Aesthetics3
Mt. Derm GmbH3
Cytrellis Biosystems, Inc.2
Eclipse Medcorp, LLC2
Esthetic Medical, Inc.2
Su-Ko Technologies, LLC2
Bellus Medical, LLC1
Bomtech Electronics Co., Ltd.1

How FDA classifies it

Class II (special controls). The special controls for this device are:

(1) The technical specifications and needle characteristics must be identified, including needle length, geometry, maximum penetration depth, and puncture rate.

(2) Non-clinical performance data must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested:

(i) Accuracy of needle penetration depth and puncture rate;

(ii) Safety features built into the device to protect against cross-contamination, including fluid ingress protection; and

(iii) Identification of the maximum safe needle penetration depth for the device for the labeled indications for use.

(3) Performance data must demonstrate the sterility of the patient-contacting components of the device.

(4) Performance data must support the shelf life of the device by demonstrating continued sterility, package integrity, and device functionality over the intended shelf life.

(5) Performance data must demonstrate the electrical safety and electromagnetic compatibility (EMC) of all electrical components of the device.

(6) Software verification, validation, and hazard analysis must be performed for all software components of the device.

(7) The patient-contacting components of the device must be demonstrated to be biocompatible.

(8) Performance data must validate the cleaning and disinfection instructions for reusable components of the device.

(9) Labeling must include the following:

(i) Information on how to operate the device and its components and the typical course of treatment;

(ii) A summary of the device technical parameters, including needle length, needle geometry, maximum penetration depth, and puncture rate;

(iii) Validated methods and instructions for reprocessing of any reusable components;

(iv) Disposal instructions; and

(v) A shelf life.

(10) Patient labeling must be provided and must include:

(i) Information on how the device operates and the typical course of treatment;

(ii) The probable risks and benefits associated with use of the device; and

(iii) Postoperative care instructions.

From 21 CFR 878.4430. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 878.4430 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent QAI clearances declared.

Ask about QAI

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about QAI

What is FDA product code QAI?

Product code QAI, “Powered Microneedle Device” in FDA's classification database, is a Class II device type under 21 CFR 878.4430 (microneedling device for aesthetic use), reviewed by FDA's General, Plastic Surgery panel. FDA's 510(k) database lists 26 clearances under QAI, 26 of them since 2011.

How many 510(k) clearances are there under QAI?

FDA’s 510(k) database listed 26 clearances under QAI as of Oct 29, 2026, 26 of them decided since 2011; the most recent decision was May 13, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a QAI 510(k)?

For the 8 QAI clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 171 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most QAI clearances?

Since 2011: Crown Aesthetics (3), Mt. Derm GmbH (3), Cytrellis Biosystems, Inc. (2), Eclipse Medcorp, LLC (2) and Esthetic Medical, Inc. (2). 18 applicants have cleared a QAI device in that time.

Sources

  1. FDA product classification: QAI · Product Classification database
  2. 21 CFR 878.4430: Microneedling device for aesthetic use · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for QAI · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow QAIGet an email when FDA clears, recalls or publishes guidance for QAI devices.

Know what FDA already cleared.